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At the dawn of the 21st century, increased
political and media attention on existing and
emerging ecologic hazards and environmental
toxicants has rekindled public anxiety about the
health consequences for future generations.
These concerns have propelled research on
genetic susceptibility and environmental condi-
tions threatening the nation’s youth. Research
approaches to conﬁrmed, suspected, or as yet
unidentified relationships between the envi-
ronment and developmental disorders have
included assessments of biologic mechanisms
through which environmental toxicants affect
children’s health, identiﬁcation of populations
that may be genetically susceptible to environ-
mental diseases, and evaluation of interventions
designed to mitigate harms associated with
environmental hazards (Sharp 2003).
The pressing need for empirically informed
public policies aimed at understanding and
promoting children’s health has challenged
environmental scientists to modify traditional
research paradigms and reevaluate their roles
and obligations toward research participants.
New methodologic approaches to children’s
environmental health research raise ethical chal-
lenges for which current federal regulations and
organizational standards may not provide suf-
ficient guidance. One such challenge is how
to construct a cohesive ethical framework for
protecting the privacy rights of children and
families participating in the diverse set of
methodologies, age groups, and populations
characterizing pediatric environmental health
research.
Data from environmental research can lead
to policies preventing or remediating environ-
mentally based developmental disorders. At
the same time, disclosure of such information
can lead to personal or group stigmatization,
restriction in employment opportunities, or
higher rates of or inability to obtain health
insurance in both childhood and adulthood.
Ethical concerns regarding the collection and
risks of disclosure of private environmental
health information not only revolve around
the principle of individual autonomy but also
relate to principles of beneficence (do good)
and nonmaleﬁcence (do no harm) (National
Commission for the Protection of Human
Subjects of Biomedical and Behavioral
Research 1978). Thus, risks to participant pri-
vacy rights need to be considered in any
risk–benefit justification for the conduct of
research. Ethical challenges are compounded
when poor and less powerful populations are
recruited for environmental hazards research.
Attention to genetic susceptibility and cultural
practices associated with environmental disease
in underserved groups can unintentionally
promote existing health disparities by placing
responsibility on the population rather than
environmental policies.
The direct and indirect implications of pri-
vacy violations on the health and social welfare
of children places the adequacy of privacy pro-
tections at the forefront of ethical concern in
the design, implementation, and dissemination
of research on children’s environmental dis-
eases. In this article I begin with a general dis-
cussion of privacy concerns and informed
consent within a pediatric environmental
health research context. I then address speciﬁc
ethical challenges associated with research on
genetic determinants of environmental risk,
prenatal studies and maternal privacy, and data
causing inﬂicted insight or affecting the infor-
mational rights of third parties.
What Is Private Information
in Environmental Health
Research?
Privacy in research refers to the right of an indi-
vidual to make decisions concerning how much
information about their physical status, health,
social network, and thoughts and feelings will
be shared with investigators. Environmental
research involving children has the potential to
collect biologic or behavioral information that
is not otherwise publicly accessible or observ-
able and to which patients or family members
do not wish others, including investigators, to
have access. Private information collected on
health status, genetic makeup, and the social
and physical environments in which children
develop requires more than conventional pri-
vacy protections. First, diseases stemming from
early exposure to environmental toxicants may
emerge at various points of the lifespan. For
this reason, pre- and postnatal data must be
stored and reanalyzed across many years. Long-
term stored data may produce information not
originally anticipated by the investigators, and
therefore not consented to by child participants
or their guardians. Blanket permission for
future analyses of such data may undermine
participant privacy if information is not deiden-
tiﬁed and the implications of future conﬁden-
tiality risks cannot be adequately determined.
Second, when research involves adult par-
ticipants, protection of privacy rights can usu-
ally be achieved through adequate informed
consent procedures. However, informed con-
sent does not provide the same protection for
children. First, children < 18 years of age do
not typically have the statutory legal right to
consent. As a result, federal regulations
[Department of Health and Human Services
(DHHS) 2005; U.S. Environmental Protection
Agency (EPA) 2006] require parental permis-
sion and in some cases child assent. Second,
because of their developmental cognitive limi-
tations, the informed assent of infants and
very young children is not required or typi-
cally sought. Third, when assent is obtained
from older children and adolescents, it is ques-
tionable whether they have the cognitive
maturity and experience to understand the
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private information. Although parent permis-
sion is a critical means of protecting the rights
of all child participants, it is unlikely that par-
ents can always anticipate how their children
will feel about third-party knowledge of their
private information as the children mature.
Fourth, the genetic privacy of biologic rela-
tives is also at risk when children or siblings
are the source of genetic information because
probabilistic inferences can be made about the
genetic traits of family members. Similarly,
epidemiologic survey questions may pose fam-
ily risks when the questions ask children to
describe items in their home or parental
health-related behaviors [Institute of Medicine
(IOM) 2005].
Federal regulations. Under current federal
regulations, an individual may be considered a
human subject if identiﬁable private informa-
tion is collected (DHHS 2005; U.S. EPA
2006). Under the Common Rule, “private
information” includes information about
behavior that occurs in a context in which an
individual can reasonably expect that no obser-
vation or recording is taking place, and infor-
mation that has been provided for specific
purposes by an individual and that the individ-
ual can reasonably expect will not be made
public (e.g., a medical record) [DHHS 2005,
45CFR46.102(f); U.S. EPA 2006, 40 CFR
Part 9]. Deﬁning what is private in environ-
mental health research poses challenges under
this regulation. For example, if parents smoke
only in the house, but not at work or in public
places, are their smoking habits a private act? If
farming families track pesticide-contaminated
mud into their home and do not clean the
floors on which their children play, is this a
private act? Does it depend on whether the
behaviors were or can be observed by family
members or neighbors?
The scientiﬁc community has not reached
consensus on distinctions between the public
and private health-related behaviors of family
members. Some have argued that health infor-
mation is not private if known by family mem-
bers (American Society of Human Genetics
2000). Others have argued that disclosures to
one’s intimates should not be considered the
same as public disclosures (Botkin et al. 1998).
In this context, Botkin et al. (1998) deﬁne pri-
vate information as “personal information over
which individuals typically want and can exert
control.” However, deﬁning what information
family members want to and are able to con-
trol is not an easy task. In the absence of con-
sultation with family representatives, it may not
be possible for investigators and institutional
review boards (IRBs) to independently construct
a “reasonable person” deﬁnition of privacy.
Unanticipated or unwanted private infor-
mation and confidentiality. An ethical chal-
lenge for environmental health research is that
it may yield private information about medical
conditions or genetic or environmental disor-
ders or risks that are unanticipated, that may
be distressing, or that parents may not want to
know or not want their children to know. This
raises issues of conﬁdentiality: the duty to pro-
tect from disclosure of private information
obtained by the investigator. This can be a
problem for both the investigator and the fam-
ily. For example, what should investigators do
if they discover that a child in a normal control
group has a biologic marker for an untreatable
disease that typically emerges in early adult-
hood? What should families or the child be
told if blood tests indicate that a 10-year-old
research participant has been exposed to levels
of an environmental toxicant associated with
sterility? What if a misattributed paternity is
discovered indicating that a child participant is
not at risk for the health problem for which he
or she was recruited into the study? Risks to
self-interest may also emerge when asympto-
matic children who have been informed about
a genetic predisposition to environmental haz-
ards must reveal in adulthood known health
vulnerabilities on health insurance or employ-
ment applications [e.g., the case of an asympto-
matic worker with a genetic susceptibility to
exposure to beryllium barred by his company
from continuing his position in a setting that
exposed him to the agent (Marshall 1999)].
Such circumstances pose a dilemma between
paternalistic policies that shield families or pri-
mary participants from information they may
wish to know and irresponsible policies that
place a burden on the family or child that can-
not be remedied (Arnold et al. 1996; Wertz
et al. 1994).
A risk of divulging unanticipated or
unwanted private information obtained during
the course of research is also economic, if
health insurance is denied or more costly
because research has identiﬁed a child as some-
one with a “preexisting” illness or at high risk
for developing an environmentally based disor-
der (Arnold et al. 1996). The Canadian
Paediatric Society (2003) “Guidelines for
Genetic Testing of Healthy Children” advises
against the genetic testing of healthy children
for disorders that may arise in adulthood. The
guidelines recommend restricting such testing
to those conditions that arise in childhood.
Based on the principle of respect for a child’s
developing autonomy and the right to medical
privacy, the guidelines reflect the view that
each individual should have the right to decide
when and if he or she wants to be tested for
predisposition to adult-onset diseases and the
right to control whether third parties will have
access to this information. The Canadian
Paediatric Society (2003) concludes that
imposing on a child genetic testing for non-
therapeutic purposes is unacceptable, even in
the context of a family situation.
Informed Consent
Informed consent is seen by many as the best
means of protecting individual privacy rights
in research. In both law and ethics, minors
have been presumed to lack the capacity to
provide informed consent because of imma-
ture cognitive skills, inadequate experiences in
situations analogous to the research context,
and the actual and perceived power differen-
tials between adolescents, parents, and clinical
researchers (Fisher 2002, 2003b; Grodin et al.
1994; IOM 2004). Under federal regulations,
the privacy rights of minor children are pro-
tected by the requirement that informed
guardian permission is obtained before a child
can participate in research. The developing
autonomy and privacy rights of children are
further protected through regulations requir-
ing that provisions are made for soliciting the
assent of the child, when he or she is capable
(DHHS 2005, 45CFR 46.408; U.S. EPA
2006, CFR 26.406).
Children’s capacity to consent. Empirical
studies suggest that children’s ability to under-
stand the nature and purpose of research and
their research rights begins to emerge in early
childhood, reaching adult levels by mid-
adolescence (Abramovitch et al. 1995;
Bruzzese and Fisher 2003; Ruck et al. 1998a,
1998b). Research also suggests that irrespec-
tive of their more mature cognitive capacities,
adolescents may not exert their research rights
because of inexperience with health care or
research decision making or out of fear of dis-
approval by parents, researchers, or clinical
staff (Abramovitch et al. 1991; Broome 1999;
Bruzzese and Fisher 2003; Scherer 1991;
Susman et al. 1992). For example, interviews
with children about their participation in
genetic susceptibility research indicated that
participants’ initial positive reaction to partic-
ipation often reﬂected an inadequate appreci-
ation of the risks and beneﬁts of sharing test
results with others or the uncertainties about
testing (Bernhardt et al. 2003).
Despite cognitive and experiential immatu-
rity, older children’s nonadult status and assent
vulnerabilities do not justify ignoring their pri-
vacy rights. Rather, when feasible, environ-
mental investigators can strive to create a
goodness of fit between children’s maturing
skills and the research context by approaching
child assent as a process of research education
fitted to the child’s age and abilities (Fisher
2002, 2003a). Given the evolving nature of
analysis of stored data, the multivariate nature
of environmental effects on children’s health,
and privacy risks that may be unfamiliar or
unanticipated at the onset of experimentation,
an educational approach to environmental
research can benefit parents as well as child
participants. Developmentally fitted assent
procedures can also help parents optimize chil-
dren’s involvement in the participation
Fisher
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to privacy (Fisher 2003a).
Cultural Attitudes toward
Shared Information
Privacy decisions are also complicated by eth-
nic variation in attitudes regarding information
sharing between parents and children (IOM
2005). For example, in some cultural groups,
an investigator’s failure to provide information
about a child’s health would be considered dis-
respectful of the parental role, whereas in other
cultural groups disclosure of private informa-
tion to family members is considered an intru-
sion on the parent–child relationship (Casas
and Thompson 1991; Fisher 2002, 2003b;
Fisher and Ragsdale 2006; Oetting and
Beauvais 1990). Moreover, ethnic minority
families, especially recently immigrated fami-
lies, may be unfamiliar with local, state, and
federal reporting laws regarding child abuse
and neglect. In these contexts, typical blanket
statements included in consent forms noting
that conﬁdentiality will be protected “except
where reporting such information is required
by law” may be uninformative at best and
deceptive at worst (Fisher et al. 2002; Trimble
and Fisher 2006).
Once language-appropriate and culturally
valid criteria for collecting and disclosing pri-
vate information have been established, when-
ever possible, investigators should identify
culturally appropriate persons and agencies
that can best serve the interests of families who
may want a referral or immediate intervention
for the participant risks identified by the
research. By partnering with community
members, schools, child welfare agencies,
courts, law enforcement agencies, and health
facilities, investigators can build culturally sen-
sitive “systems of protection” that define
when, how, and to whom environmental
health data will be reported in a manner con-
sistent with both participant cultural values
and laws governing reporting (Fisher et al.
2002; IOM 2005; Minkler and Wallerstein
2003). According to the Centers for Disease
Control and Prevention (CDC 1997), strate-
gies to engage communities include capacity
building, coalition building, and community
organizing (see also Lerner et al. 2000).
Studies of Genetic
Predisposition to
Environmentally Related
Diseases
The Human Genome Project has paved the
way to discovering individual differences in
genetic predispositions to diseases associated
with exposure to hazardous environmental
materials. Findings from gene–environment
epidemiologic studies have the potential to
inﬂuence policies that reduce environmentally
related diseases and create safer living and
occupational environments. Information gained
from research on the interactions between genes
and environment may also be used by busi-
nesses to justify declining health insurance,
housing, or employment. Responsible science
therefore requires strict enforcement of conﬁ-
dentiality protections for individually identiﬁ-
able information gained from such research.
Sharing research-derived genetic informa-
tion with parents. In situations in which inves-
tigators will share results of genetic testing with
parents, the child has no say in whether others
will be privy to one of the most private ele-
ments of individuality, one’s genetic makeup.
In addition, a unique aspect of genetic research
involving neonates or children is that others
know highly personal information about them
of which they are unaware and may remain
unaware. Informing parents about a newborn
or child’s genetic vulnerability to environmental
disease discovered during research participation
can be ethically appropriate when interventions
exist that can reduce such vulnerability. In such
cases, the principle of beneficence may have
privileged status over the principle of respect for
individual privacy. However, the same decision
may not be morally appropriate in situations in
which guardians are given information about
their child’s genetic makeup when the chance
of the child developing an environmental dis-
ease in the future is only probabilistic and treat-
ment will not inﬂuence whether the child will
develop the disease (Ross 2002).
Sharing with parents their child’s genetic
susceptibility information obtained from
asymptomatic children can unintentionally
threaten the child’s best interest. Parents may
treat children differently based on knowledge
of their potential genetic predisposition to dis-
ease. Although parental efforts to avoid unnec-
essary environmental hazards may be a positive
consequence of sharing children’s private
genetic information, negative consequences
can also occur. Parents may become over-
protective or overly pessimistic about the
child’s future, resulting in a restriction of activ-
ities and opportunities the child might have
otherwise been afforded.
Scientific documentation and available
interventions. Decisions to share experimen-
tally derived information about a child’s
genetic makeup should rest on the certainty of
scientiﬁc documentation. The weaker the sci-
entific foundation is for a hypothesized rela-
tionship between a genetic test and an
environmental disease, the weaker the moral
argument to violate a child’s genetic privacy
rights. The direct application of environmental
health research to understanding causal mecha-
nisms for environmental disorders of child-
hood can be limited. For example, when
complex chemical exposures (e.g., air pollu-
tion) are investigated, biomarkers may reﬂect a
reaction to one particular component of the
mixture, when in fact the health disorder arises
from another component (Soskolne 1997).
Disclosure of genetic information obtained
through research should occur only if the
hereditary nature of environmental disease sus-
ceptibility has been clearly demonstrated, the
disease presents a major risk to the child’s
future health, there is a low probability of false
positives, and remedies are possible (Grandjean
and Sorsa 1996). Along these lines, Annas et al.
(1995) have argued that the right of parents to
give permission to the collection and analysis of
a child’s DNA be prohibited for children < 16
years of age for any condition that will not
develop until adulthood, unless some effective
measure can be taken before adulthood to pre-
vent or ameliorate the disease. Such limitations
on access to DNA information should be pro-
vided to the parents and child at the time of
informed consent so that parents who do not
agree with the restriction can refuse their child’s
participation.
Research on genetic susceptibility to child-
hood asthma or adult lung cancer from early
exposure to air pollutants provides a good
example of this approach. Within this frame-
work, it might be ethically permissible and,
indeed, ethically responsible for investigators to
inform parents about their child’s genotype if
a) research had demonstrated a strong correla-
tion between the genotype and development of
environmentally induced asthma, b) the speciﬁc
air pollutants triggering the asthmatic condition
were identiﬁed, and c) it was possible to limit or
remove the child from exposure to this pollu-
tant. On the other hand, from a genetic privacy
perspective, it might not be ethically responsible
to inform parents about their child’s genotype if
a) research indicated a low but signiﬁcant corre-
lation between the genotype and susceptibility
to adult lung cancer, b) the specific element
within a complex pollutant triggering environ-
mental adult lung cancer had not been identi-
ﬁed, and c) it was difﬁcult to recommend with
conﬁdence an environment that would reduce
any potential risk.
The right not to know. Many adults do not
wish to know their chances of developing an
environmental disease. Federal guidelines per-
mit the “right not to know” option in cases in
which early treatment is not available [Ofﬁce
for Protection from Research Risks (OPRR)
1993]. Guidance is unclear concerning the role
of guardians in determining a child or adoles-
cent’s right to know or not know of a medical
condition or environmental risk revealed
through research. When children participate in
genetic predisposition studies, they may be
deprived of the opportunity afforded adult par-
ticipants to refuse to be informed about their
disease susceptibility. Thus, predictive genetic
research involving children may violate both
their right to refuse invasive data collection
procedures and their right to withhold or not
Privacy and ethics in pediatric environmental research: part I
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their self-interests (Grandjean and Sorsa 1996).
One approach to resolving this problem is to
inform parents that children will be notified
that such genetic information is available when
the child turns 18 (Fisher et al. 1996)
Distinctions between genetic testing for
research versus treatment. The threshold for
granting parents the right to give permission
for the collection of their child’s genetic infor-
mation without the child’s assent should be
higher when such information is collected
solely for research purposes than when it is
collected as part of diagnostic assessment and
treatment decisions that will directly affect the
child’s health. Such a position is compatible
with federal regulations permitting IRBs to
approve research that allows parental permis-
sion to override child dissent when participa-
tion in a research study holds out a prospect of
direct benefit to the child’s health or well-
being available only in the context of the
research (DHHS 2005, 45CFR46.408a). 
Prenatal Research and
Maternal Privacy
Data collection during the prenatal period is
important to ascertain aspects of the fetal envi-
ronment that may contribute to congenital
anomalies or later diseases related to maternal
exposure to environmental toxicants. Agents
investigated can include aspects of the physical
environment of which the pregnant woman is
unaware or that are unknown, such as air pollu-
tants or lead contaminants, or agents the
mother has intentionally ingested, such as
antibiotics, antiallergens, hair dyes, illicit drugs,
or high levels of alcohol for which prenatal risks
are or are not known. Umbilical cord blood
(UCB) is a frequently used source of informa-
tion for identifying infant biologic markers and
prenatal exposure to toxicants. Women are
often asked to contribute UCB soon after deliv-
ery when they may not be fully informed about
the type of personal data that will be stored in
UCB banks (Sugarman et al. 1998). After con-
sent, mothers may be asked about their sexual
and medical history or their blood may be
tested for infectious diseases, such as HIV and
hepatitis. Prenatal studies may intrude on
maternal privacy by asking whether pregnancies
were conceived through reproductive technolo-
gies or provide information on a child’s pater-
nity that was either unknown by the woman or
that she did not wish to be revealed.
Private information about both the mother
and fetus collected during the prenatal period
may be stored in registries used in epidemio-
logic studies to monitor temporal or geographic
patterns. To be of scientiﬁc and social value,
registries must include minimal demographic
information about the mother (i.e., age, ethnic-
ity, and type of employment if it is relevant to
potential exposure to environmental toxicants)
and geographic region, as well as linkages
between various sources of information about
the mother and the fetus or newborn that at
some point in the process must include a
unique identiﬁer that may pose privacy risks for
the mother.
Investigators and IRBs need to be aware
that risks to pregnant women outlined in this
section raise issues of distributive social justice
because the risks are assumed primarily by
women rather than men. Thus, calculations of
the ratio of scientiﬁc beneﬁt to the conﬁdential-
ity and privacy risks associated with such stud-
ies need to consider whether it is fair to burden
one segment of the population with such risk.
Maternal privacy risks during prenatal
testing. Collection of maternal urine samples or
amniotic ﬂuid to identify toxicants that may be
associated with congenital anomalies may
uncover maternal use of illicit drugs or illegal
use of prescription drugs that can lead to crimi-
nal investigation, a child welfare complaint,
loss of food stamps, or loss of Supplemental
Security Income. Identiﬁcation of toxicants in
biologic samples from the mother or infant
may also lead to disqualifications regarding
maternal employment opportunities, social
stigma, legal risk, or self-recrimination (Harvey
et al. 2002). For example, Grandjean and Sorsa
(1996) describe an instance in which a manu-
facturing company excluded smokers from
work sites with asbestos exposure because of
data indicating smoking might increase suscep-
tibility to asbestos-related lung cancer.
Another threat to privacy can arise when,
for recruitment purposes, physicians are
alerted to the need for research on a suspected
teratogenic agent unique to a speciﬁc maternal
demographic. In these circumstances, whether
or not the mother agrees to participate in the
study, her physician may ask questions or con-
duct invasive tests that would not otherwise be
required, and her refusal to take such tests may
stigmatize her as a neglectful or incompetent
mother (Marshall et al. 2003). Additional pri-
vacy risks can emerge when women give per-
mission for data from amniocentesis to be
collected and the results of the amniocentesis
lead to a decision to terminate the preg-
nancy—a decision that may be included in the
data record.
Maternal rights versus the information
rights of other family members. Data on mater-
nal exposure to or ingestion of teratogenic
agents also raise questions regarding the rights
of other family members to this information.
Does the child’s biologic or legal father have the
right to maternal environmental exposure infor-
mation hypothesized to be linked to fetal or
child health? Does the decision depend on the
extent to which the hypothesized link has been
empirically demonstrated? Although physicians
may not be legally required to share such
information, their participation in recruitment
and data collection may be judged within a dif-
ferent set of ethical and legal medical principles.
Do adult children with congenital anom-
alies or other health problems associated with
maternal exposures or ingestion of environ-
mental toxicants have the right to know about
their mother’s environmental history if the
information is available in data banks? The
answer to this question may rest on the source
of information. For example, if information
on the mother’s exposure or ingestion of the
teratogen was acquired through analysis of
amniotic ﬂuid, fetal tissue, or UCB, one might
conclude that the child, not the mother, was
the data donor, with all the informational
privileges attached to donor status. Ethical
decisions regarding these complex issues must
be made during the design phases of the
research so that IRBs can help investigators
ensure that mothers are adequately informed
about the immediate or future risks to privacy
they may face. 
Pregnant adolescents. Environmental
health research involving teenage participants
raise additional challenges in the arena of child
and maternal rights. First, whether or not a
pregnant teenager can provide legal indepen-
dent consent to research participation depends
on individual state laws governing the age and
circumstances under which teenagers are con-
sidered mature or emancipated minors. In
some states, for example, teenage mothers can
provide consent for their infant’s participation
in research but not for their own participation.
Thus, in some instances, family members as
legal guardians may have access to information
about the adolescent mother’s exposure to or
ingestion of teratogenic agents that would not
be accessible if the mother were legally recog-
nized as an adult (English 1995; Santelli et al.
1995).
A second concern arises in developmental
studies of child and adolescent exposure to
environmental toxicants. For such studies, ado-
lescents may with parental permission assent to
blood tests or other biologic assays to determine
the presence of such toxicants. In some
instances, these tests may indicate that the ado-
lescent is pregnant, when the adolescent is not
aware of the pregnancy and/or she does not
want her parents to be notiﬁed. Disclosing such
information to the adolescent may be perceived
as a violation of privacy if the informed consent
information did not include the possibility that
a pregnancy could be detected. In other
instances, the pregnancy may disqualify adoles-
cents from continued participation in the study,
leading to questions about the discontinuation
from her parents. Is telling the parents the rea-
son for discontinuation a violation of the ado-
lescent’s conﬁdentiality? Should investigators
engage in deceptive explanations to parents
about the reason for withdrawing the child
from study participation? Should they continue
Fisher
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the intention of disqualifying the data, which in
turn may violate their obligation to the agency
funding the research? The best way to protect
the privacy and conﬁdentiality of female adoles-
cent participants in these contexts is to plan in
advance the disclosure procedures that will be
most appropriate and least harmful to partici-
pants and their families and communicate what
these procedures will be to both parents and
adolescents during informed consent.
Conclusion
Environmental health research has played and
will continue to play a critical role in helping
to identify environmental risks to children and
to develop child-protective environmental poli-
cies. Research on the interaction between envi-
ronmental agents and pediatric susceptibility
has not kept pace with the large number of
chemicals children are exposed to on a daily
basis. Children’s physiology is different from
that of adults and animals, and extrapolations
from nonpediatric studies are in most cases
insufﬁcient to adequately determine pediatric
environmental risk. Little remains known
about genetic susceptibilities in children, and
the vast majority of environmental agents have
not been tested for pediatric toxicity. The need
for environmental health research involving
children has never been greater, nor has the
need for consensus on how to conduct such
research responsibly.
The moral claims of children in environ-
mental health research are no different from
those of adults. Children have the right to
assume that scientists will communicate with
them honestly, do them no harm, treat them
fairly, and protect their autonomy and privacy.
Respectful and compassionate research involv-
ing children requires understanding of chil-
dren’s ways of thinking, their assent strengths
and weaknesses, life experiences, and practical
and family concerns. Environmental health
investigators can help protect children’s privacy
needs through developmentally ﬁtted efforts to
ensure that these claims are met (Fisher
2003a). For example, children have limited
experience exercising their rights in response to
requests from adult authority ﬁgures, especially
within health care or other unfamiliar settings
(Bruzzese and Fisher 2003). Constructing pro-
cedures that concretely demonstrate that dis-
sent will not be penalized and providing
opportunities to practice decision making can
optimize voluntary participation choices.
Additionally, the informed consent process for
longitudinal studies and studies that will result
in the creation of long-term databases must be
viewed as a continuous process, with reconsent
procedures that fit children’s maturing
decisional capacities and parental concerns.
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